Shopping Cart
- Remove All
Your shopping cart is currently empty
L-902688 is an orally active EP4 receptor agonist (Ki: 0.38 nM; EC50: 0.6 nM). L-902688 displays >4,000-fold selective for EP4 over other EP and prostanoid receptors.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 500 μg | $397 | 35 days | |
| 1 mg | $768 | 35 days | |
| 5 mg | $3,420 | 35 days | |
| 10 mg | $5,920 | 35 days |
| Description | L-902688 is an orally active EP4 receptor agonist (Ki: 0.38 nM; EC50: 0.6 nM). L-902688 displays >4,000-fold selective for EP4 over other EP and prostanoid receptors. |
| Targets&IC50 | EP4:0.6 nM (EC50), EP4:0.38 nM (ki) |
| In vitro | L-902688 (1 μM; 24 hours; HUVE cells) treatment, decreases TGF-β-induced Twist and α-smooth muscle actin (α-SMA) expression. |
| In vivo | In the monocrotaline (MCT)-induced PAH rat model, L-902688 (0.25-1 μg/kg/day; intraperitoneal injection; daily; for 3 weeks; adult male Sprague-Dawley rats) treatment decreases right ventricle fibrosis [1]. |
| Molecular Weight | 419.47 |
| Formula | C21H27F2N5O2 |
| Cas No. | 634193-54-7 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.